Functional analysis of a tripartite stability element within the CD40 ligand 3′ untranslated region

Immunology - Tập 124 Số 3 - Trang 368-379 - 2008
Jennifer Laughlin1, Sanaz Oghlidos1, Joseph F. Porter1, Rodrigo Matus‐Nicodemos1, Frank L. Sinquett1, Valentina Marcelli1, Lori R. Covey1
1Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ, USA

Tóm tắt

Summary

We previously identified a cis‐acting element within the 3′ untranslated region of CD40 ligand messenger RNA (mRNA) that is composed of three complex binding sites and acts to increase mRNA stability in both in vitro and in vivo systems. We now demonstrate the functional consequences of the three binding sites with respect to increasing both luciferase activity and mRNA stability in a heterologous transcript expressed in a T‐cell line. The internal region B was shown to be a bona fide stability element because its presence increased luciferase activity fourfold over the unmodified transcript and its removal from the XbaI–HaeIII region resulted in rapid degradation of the transcript. Region A contained both a binding site for a polypyrimidine‐tract‐binding protein (PTB)‐mediated complex (Complex I) and an upstream, adjacent sequence that was a negative regulator of mRNA stability. Region C bound Complex II, which contained both PTB and heterogeneous nuclear ribonucleoproteinL (hnRNPL), and was less effective as a stability element on its own compared to region B. Our findings demonstrate differential levels of activity for the three binding sites relative to the turnover of CD40 ligand mRNA, suggesting that the lack of binding of Complex I/II during the early stages of T‐cell activation contributes to the rapid degradation of the CD40 ligand mRNA transcript.

Từ khóa


Tài liệu tham khảo

10.1146/annurev.iy.12.040194.004313

10.1016/1074-7613(94)90095-7

10.1016/1074-7613(94)90073-6

10.1016/0092-8674(93)90668-G

10.1038/361539a0

10.1126/science.7679801

10.1073/pnas.90.6.2170

10.1002/eji.1830230936

10.1146/annurev.immunol.14.1.591

10.1016/S1074-7613(00)80408-2

10.1146/annurev.immunol.16.1.111

10.1038/381434a0

10.1073/pnas.93.24.13967

10.1073/pnas.94.16.8789

10.1038/28204

10.1002/eji.1830221016

10.1084/jem.175.4.1091

Castle BE, 1993, Regulation of expression of the ligand for CD40 on T helper lymphocytes, J Immunol, 151, 1777, 10.4049/jimmunol.151.4.1777

10.1002/eji.1830231212

10.1002/eji.1830230430

Klaus SJ, 1994, Costimulation through CD28 enhances T cell‐dependent B cell activation via CD40‐CD40L interaction, J Immunol, 152, 5643, 10.4049/jimmunol.152.12.5643

Yellin MJ, 1994, CD40 molecules induce down‐modulation and endocytosis of T cell surface T cell‐B cell activating molecule/CD40‐L, J Immunol, 152, 598, 10.4049/jimmunol.152.2.598

10.1002/eji.1830240402

10.1002/eji.1830260418

10.1002/eji.1830261246

10.1093/intimm/8.2.275

10.1002/eji.1830240303

10.4049/jimmunol.166.7.4578

10.4049/jimmunol.166.4.2437

10.1172/JCI117089

10.1074/jbc.270.50.29624

10.1074/jbc.271.7.3763

10.1074/jbc.M110350200

10.1046/j.1365-2249.2001.01601.x

10.1038/ni1378

10.1002/eji.1830271112

Ford GS, 1998, CD40 ligand exerts differential effects on the expression of Iγ transcripts in subclones of an IgM+ human B cell lymphoma line, J Immunol, 160, 595, 10.4049/jimmunol.160.2.595

Rigby WF, 1999, Characterization of RNA binding proteins associated with CD40 ligand (CD154) mRNA turnover in human T lymphocytes, J Immunol, 163, 4199, 10.4049/jimmunol.163.8.4199

Murakami K, 1999, Human endothelial cells augment early CD40 ligand expression in activated CD4+ T cells through LFA‐3‐mediated stabilization of mRNA, J Immunol, 163, 2667, 10.4049/jimmunol.163.5.2667

10.4049/jimmunol.165.8.4478

Ford GS, 1999, Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation, J Immunol, 162, 4037, 10.4049/jimmunol.162.7.4037

10.1126/science.2540528

10.1126/science.280.5371.1945

10.4049/jimmunol.170.2.979

10.1128/MCB.23.2.510-525.2003

10.4049/jimmunol.173.2.976

Yellin MJ, 1991, A human CD4‐leukemic subclone with contact‐dependent helper function, J Immunol, 147, 3389, 10.4049/jimmunol.147.10.3389

10.1006/meth.2001.1262

10.1093/nar/29.9.e45

10.1093/emboj/19.2.295

10.1128/MCB.20.17.6334-6341.2000

10.1016/S0014-5793(98)00269-5

10.1016/S0092-8674(00)00210-5

10.1016/j.molimm.2007.01.029

Thông tin
Thông tin xuất bản

Immunology

Tập 124 Số 3

368-379

Thông tin tác giả